Cited 14 times in
Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 심효섭 | - |
dc.date.accessioned | 2014-12-18T08:37:29Z | - |
dc.date.available | 2014-12-18T08:37:29Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 1738-1843 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/86653 | - |
dc.description.abstract | Mutations of the epidermal growth factor receptor (EGFR) are the strongest predictive factor for response to EGFR tyrosine kinase inhibitors (TKIs), such as gefitinib and erlotinib. EGFR TKIs are approved in Korea as a first-line treatment for lung cancer patients with mutated EGFR. Rapid and accurate EGFR mutation testing is essential for patient selection and establishing targeted therapies with EGFR TKIs. Thus, a standard set of guideline recommendations for EGFR mutation testing suitable for the Korean medical community is necessary. In this article, we propose a set of guideline recommendations for EGFR mutation testing that was discussed and approved by the Cardiopulmonary Pathology Study Group of the Korean Society of Pathologists. | - |
dc.description.statementOfResponsibility | open | - |
dc.relation.isPartOf | KOREAN JOURNAL OF PATHOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.title | Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pathology (병리학) | - |
dc.contributor.googleauthor | Hyo Sup Shim | - |
dc.contributor.googleauthor | Jin-Haeng Chung | - |
dc.contributor.googleauthor | Lucia Kim | - |
dc.contributor.googleauthor | Sunhee Chang | - |
dc.contributor.googleauthor | Wan-Seop Kim | - |
dc.contributor.googleauthor | Geon Kook Lee | - |
dc.contributor.googleauthor | Soon-Hee Jung | - |
dc.contributor.googleauthor | Se Jin Jang | - |
dc.identifier.doi | 10.4132/KoreanJPathol.2013.47.2.100 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A02219 | - |
dc.relation.journalcode | J02092 | - |
dc.identifier.eissn | 2092-8920 | - |
dc.identifier.pmid | 23667368 | - |
dc.subject.keyword | Guideline | - |
dc.subject.keyword | Mutation | - |
dc.subject.keyword | Receptor, epidermal growth factor | - |
dc.contributor.alternativeName | Shim, Hyo Sup | - |
dc.contributor.affiliatedAuthor | Shim, Hyo Sup | - |
dc.rights.accessRights | free | - |
dc.citation.volume | 47 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 100 | - |
dc.citation.endPage | 106 | - |
dc.identifier.bibliographicCitation | KOREAN JOURNAL OF PATHOLOGY , Vol.47(2) : 100-106, 2013 | - |
dc.identifier.rimsid | 29122 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.